Intensity Therapeutics In...

NASDAQ: INTS · Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM

Intensity Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 282.22K 282.22K 282.22K 282.22K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
12K 18K 17.89K 19.91K 52.53K 147K 186.54K 229.5K 235.41K 179.04K 133.6K 88.63K 44.09K 42.4K 42.4K 42.4K 42.4K
Gross Profit
-6K -12K 264.32K 262.31K 229.69K 135.22K -186.54K -229.5K -235.41K -179.04K -133.6K -88.63K -44.09K -42.4K -42.4K -42.4K -42.4K
Operating Income
-15.24M -16.59M -16.73M -15.66M -11.81M -8.32M -6.52M -5.8M -6.52M -7.66M -8.52M -8.89M -8.91M -8.01M -7.26M -5.12M -3.16M
Interest Income
189K 314K 461.97K 561.51K 463.68K 324K 148.66K 2.11K 2.15K 2.48K 2.19K 1.85K 2.51K 2.61K 8.24K 7.59K 6.72K
Pretax Income
-15.01M -16.27M -16.26M -15.07M -13.8M -10.54M -8.88M -8.32M -6.55M -7.58M -8.47M -8.82M -8.79M -7.9M -7.13M -5M -3.11M
Net Income
-15.01M -16.27M -16.26M -15.07M -13.8M -10.54M -8.88M -8.32M -6.53M -7.56M -8.46M -8.81M -8.79M -7.9M -7.13M -5M -3.11M
Selling & General & Admin
5.37M 6.08M 6.39M 6.11M 4.97M 3.53M 2.57M 2.03M 2.23M 2.45M 2.84M 2.87M 2.57M 2.16M 1.44M 795.68K 534.63K
Research & Development
9.87M 10.5M 10.33M 9.53M 6.83M 4.79M 3.88M 3.68M 4.21M 5.13M 5.68M 6.02M 6.33M 5.86M 5.83M 4.33M 2.62M
Other Expenses
n/a n/a 5.7K 18.93K 23.27K 24K 18.3K 12.19K 24.74K 47.65K 56.43K 61.84K 117.81K 115.51K 123.48K 110.95K 38.09K
Operating Expenses
15.24M 16.58M 16.72M 15.64M 11.8M 8.31M 6.44M 5.72M 6.44M 7.58M 8.52M 8.89M 8.91M 8.01M 7.26M 5.12M 3.16M
Interest Expense
n/a n/a n/a n/a 221.78K 305.16K 342.06K 357.19K 135.62K 52.88K 16.33K 1.85K 2.51K 2.61K 8.24K 7.59K 6.72K
Selling & Marketing Expenses
n/a -6K -11.89K -11.89K -11.89K -5.89K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.84M 16.59M 16.73M 15.66M 11.81M 8.32M 6.44M 5.72M 6.44M 7.58M 8.52M 8.89M 8.91M 8.01M 7.26M 5.12M 3.16M
Income Tax Expense
37.28K n/a -37.28K -184.82K 36.79K 74.42K 73.36K 235.03K -3.9K -29.17K -37.59K -66.19K -105.55K -123.78K -175.41K -160.94K -104.25K
Shares Outstanding (Basic)
15.17M 14.63M 13.8M 13.71M 13.71M 13.71M 13.71M 13.1M 13.1M 13.1M 3.52M 17.99M 13.1M 17.99M 17.99M 17.99M 3.52M
Shares Outstanding (Diluted)
15.17M 14.63M 13.8M 13.71M 13.71M 13.71M 13.71M 13.1M 13.1M 13.1M 3.52M 17.99M 13.1M 17.99M 17.99M 17.99M 22.89M
EPS (Basic)
-1.06 -1.18 -1.18 -1.1 -1.02 -0.78 -0.67 -1 -0.83 -0.91 -0.92 -0.54 -0.54 -0.78 -0.74 -0.62 -0.51
EPS (Diluted)
-1.06 -1.18 -1.18 -1.1 -1.02 -0.78 -0.67 -1 -0.83 -0.91 -0.92 -0.54 -0.54 -0.42 -0.39 -0.27 -0.16
EBITDA
-15.05M -16.25M -16.24M -15.06M -13.53M -10.09M -8.39M -7.79M -6.23M -7.4M -8.34M -8.75M -8.83M -8M -7.26M -5.12M -3.16M
EBIT
-11.66M -16.27M -16.26M -15.08M -13.58M -10.23M -8.57M -8M -6.44M -7.54M -8.44M -8.82M -8.87M -8.01M -7.26M -5.12M -3.16M
Depreciation & Amortization
69K 75K 74.89K 19.91K 52.53K 147K 186.54K 229.5K 235.41K 179.04K 143.09K 111.93K 123.21K 121.52K 167.16K 153.34K 97.53K